Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $6.07 million. The enterprise value is -$10.75 million.
| Market Cap | 6.07M |
| Enterprise Value | -10.75M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 18.95 million shares outstanding. The number of shares has increased by 191.02% in one year.
| Shares Outstanding | 18.95M |
| Shares Change (YoY) | +191.02% |
| Shares Change (QoQ) | +169.39% |
| Owned by Insiders (%) | 0.50% |
| Owned by Institutions (%) | 0.50% |
| Float | 18.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.22 |
| PS Ratio | 0.23 |
| Forward PS | 0.16 |
| PB Ratio | 0.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.41 |
| Quick Ratio | 3.10 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.56 |
Financial Efficiency
Return on equity (ROE) is -17.90% and return on invested capital (ROIC) is -16.94%.
| Return on Equity (ROE) | -17.90% |
| Return on Assets (ROA) | -14.20% |
| Return on Capital (ROIC) | -16.94% |
| Revenue Per Employee | $607,722 |
| Profits Per Employee | -$92,896 |
| Employee Count | 44 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 3.13 |
Taxes
In the past 12 months, SBFM has paid $371,249 in taxes.
| Income Tax | 371,249 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.37% in the last 52 weeks. The beta is -1.09, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | -1.09 |
| 52-Week Price Change | -99.37% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 16.10 |
| Relative Strength Index (RSI) | 33.37 |
| Average Volume (20 Days) | 3,937,821 |
Short Selling Information
The latest short interest is 1.57 million, so 8.30% of the outstanding shares have been sold short.
| Short Interest | 1.57M |
| Short Previous Month | 157,758 |
| Short % of Shares Out | 8.30% |
| Short % of Float | 8.32% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
In the last 12 months, SBFM had revenue of $26.74 million and -$4.09 million in losses. Loss per share was -$13.70.
| Revenue | 26.74M |
| Gross Profit | 8.87M |
| Operating Income | -4.31M |
| Pretax Income | -3.72M |
| Net Income | -4.09M |
| EBITDA | -3.41M |
| EBIT | -3.57M |
| Loss Per Share | -$13.70 |
Balance Sheet
The company has $17.43 million in cash and $612,366 in debt, giving a net cash position of $16.82 million or $0.89 per share.
| Cash & Cash Equivalents | 17.43M |
| Total Debt | 612,366 |
| Net Cash | 16.82M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 24.82M |
| Book Value Per Share | 1.31 |
| Working Capital | 22.30M |
Cash Flow
In the last 12 months, operating cash flow was -$10.11 million and capital expenditures -$15,400, giving a free cash flow of -$10.13 million.
| Operating Cash Flow | -10.11M |
| Capital Expenditures | -15,400 |
| Free Cash Flow | -10.13M |
| FCF Per Share | -$15.79 |
Margins
Gross margin is 33.15%, with operating and profit margins of -16.11% and -15.29%.
| Gross Margin | 33.15% |
| Operating Margin | -16.11% |
| Pretax Margin | -13.90% |
| Profit Margin | -15.29% |
| EBITDA Margin | -12.77% |
| EBIT Margin | -13.35% |
| FCF Margin | -37.87% |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -191.02% |
| Shareholder Yield | -191.02% |
| Earnings Yield | -67.34% |
| FCF Yield | -166.81% |
Analyst Forecast
The average price target for SBFM is $260.00, which is 81,048.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $260.00 |
| Price Target Difference | 81,048.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 17, 2024. It was a reverse split with a ratio of 1:100.
| Last Split Date | Apr 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
SBFM has an Altman Z-Score of -1.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.04 |
| Piotroski F-Score | 3 |